Industry: Medical Devices & Consumables
Published Date: 2025-01-13
Pages: 111 Pages
Report ld: 3501730
Request Sample
Customized Report
Angiographic Interventional Therapy System Market Size(US$)

CAGR 2025-2031
11.9%
Market Size,2031
USD 125,640
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Angiographic Interventional Therapy System was estimated to be worth US$ 57840 million in 2024 and is forecast to a readjusted size of US$ 125640 million by 2031 with a CAGR of 11.9% during the forecast period 2025-2031.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Angiographic Interventional Therapy System, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Angiographic Interventional Therapy System by region & country, by Type, and by Application.
The Angiographic Interventional Therapy System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Angiographic Interventional Therapy System.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Angiographic Interventional Therapy System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Angiographic Interventional Therapy System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Angiographic Interventional Therapy System in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Angiographic Interventional Therapy System Product Introduction
1.2 Global Angiographic Interventional Therapy System Market Size Forecast
1.2.1 Global Angiographic Interventional Therapy System Sales Value (2020-2031)
1.2.2 Global Angiographic Interventional Therapy System Sales Volume (2020-2031)
1.2.3 Global Angiographic Interventional Therapy System Sales Price (2020-2031)
1.3 Angiographic Interventional Therapy System Market Trends & Drivers
1.3.1 Angiographic Interventional Therapy System Industry Trends
1.3.2 Angiographic Interventional Therapy System Market Drivers & Opportunity
1.3.3 Angiographic Interventional Therapy System Market Challenges
1.3.4 Angiographic Interventional Therapy System Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Angiographic Interventional Therapy System Players Revenue Ranking (2024)
2.2 Global Angiographic Interventional Therapy System Revenue by Company (2020-2025)
2.3 Global Angiographic Interventional Therapy System Players Sales Volume Ranking (2024)
2.4 Global Angiographic Interventional Therapy System Sales Volume by Company Players (2020-2025)
2.5 Global Angiographic Interventional Therapy System Average Price by Company (2020-2025)
2.6 Key Manufacturers Angiographic Interventional Therapy System Manufacturing Base and Headquarters
2.7 Key Manufacturers Angiographic Interventional Therapy System Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Angiographic Interventional Therapy System
2.9 Angiographic Interventional Therapy System Market Competitive Analysis
2.9.1 Angiographic Interventional Therapy System Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Angiographic Interventional Therapy System Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Angiographic Interventional Therapy System as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 X-ray Angiography
3.1.2 CT Angiography
3.1.3 Magnetic Resonance Angiography
3.1.4 MR-CT Angiography
3.2 Global Angiographic Interventional Therapy System Sales Value by Type
3.2.1 Global Angiographic Interventional Therapy System Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Angiographic Interventional Therapy System Sales Value, by Type (2020-2031)
3.2.3 Global Angiographic Interventional Therapy System Sales Value, by Type (%) (2020-2031)
3.3 Global Angiographic Interventional Therapy System Sales Volume by Type
3.3.1 Global Angiographic Interventional Therapy System Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Angiographic Interventional Therapy System Sales Volume, by Type (2020-2031)
3.3.3 Global Angiographic Interventional Therapy System Sales Volume, by Type (%) (2020-2031)
3.4 Global Angiographic Interventional Therapy System Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Cardiology
4.1.2 Oncology
4.1.3 Neurology
4.1.4 Peripheral Vascular Intervention
4.2 Global Angiographic Interventional Therapy System Sales Value by Application
4.2.1 Global Angiographic Interventional Therapy System Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Angiographic Interventional Therapy System Sales Value, by Application (2020-2031)
4.2.3 Global Angiographic Interventional Therapy System Sales Value, by Application (%) (2020-2031)
4.3 Global Angiographic Interventional Therapy System Sales Volume by Application
4.3.1 Global Angiographic Interventional Therapy System Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Angiographic Interventional Therapy System Sales Volume, by Application (2020-2031)
4.3.3 Global Angiographic Interventional Therapy System Sales Volume, by Application (%) (2020-2031)
4.4 Global Angiographic Interventional Therapy System Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Angiographic Interventional Therapy System Sales Value by Region
5.1.1 Global Angiographic Interventional Therapy System Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Angiographic Interventional Therapy System Sales Value by Region (2020-2025)
5.1.3 Global Angiographic Interventional Therapy System Sales Value by Region (2026-2031)
5.1.4 Global Angiographic Interventional Therapy System Sales Value by Region (%), (2020-2031)
5.2 Global Angiographic Interventional Therapy System Sales Volume by Region
5.2.1 Global Angiographic Interventional Therapy System Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Angiographic Interventional Therapy System Sales Volume by Region (2020-2025)
5.2.3 Global Angiographic Interventional Therapy System Sales Volume by Region (2026-2031)
5.2.4 Global Angiographic Interventional Therapy System Sales Volume by Region (%), (2020-2031)
5.3 Global Angiographic Interventional Therapy System Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Angiographic Interventional Therapy System Sales Value, 2020-2031
5.4.2 North America Angiographic Interventional Therapy System Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Angiographic Interventional Therapy System Sales Value, 2020-2031
5.5.2 Europe Angiographic Interventional Therapy System Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Angiographic Interventional Therapy System Sales Value, 2020-2031
5.6.2 Asia Pacific Angiographic Interventional Therapy System Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Angiographic Interventional Therapy System Sales Value, 2020-2031
5.7.2 South America Angiographic Interventional Therapy System Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Angiographic Interventional Therapy System Sales Value, 2020-2031
5.8.2 Middle East & Africa Angiographic Interventional Therapy System Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Angiographic Interventional Therapy System Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Angiographic Interventional Therapy System Sales Value
6.2.1 Key Countries/Regions Angiographic Interventional Therapy System Sales Value, 2020-2031
6.2.2 Key Countries/Regions Angiographic Interventional Therapy System Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Angiographic Interventional Therapy System Sales Value, 2020-2031
6.3.2 United States Angiographic Interventional Therapy System Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Angiographic Interventional Therapy System Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Angiographic Interventional Therapy System Sales Value, 2020-2031
6.4.2 Europe Angiographic Interventional Therapy System Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Angiographic Interventional Therapy System Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Angiographic Interventional Therapy System Sales Value, 2020-2031
6.5.2 China Angiographic Interventional Therapy System Sales Value by Type (%), 2024 VS 2031
6.5.3 China Angiographic Interventional Therapy System Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Angiographic Interventional Therapy System Sales Value, 2020-2031
6.6.2 Japan Angiographic Interventional Therapy System Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Angiographic Interventional Therapy System Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Angiographic Interventional Therapy System Sales Value, 2020-2031
6.7.2 South Korea Angiographic Interventional Therapy System Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Angiographic Interventional Therapy System Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Angiographic Interventional Therapy System Sales Value, 2020-2031
6.8.2 Southeast Asia Angiographic Interventional Therapy System Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Angiographic Interventional Therapy System Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Angiographic Interventional Therapy System Sales Value, 2020-2031
6.9.2 India Angiographic Interventional Therapy System Sales Value by Type (%), 2024 VS 2031
6.9.3 India Angiographic Interventional Therapy System Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 GE Healthcare
7.1.1 GE Healthcare Company Information
7.1.2 GE Healthcare Introduction and Business Overview
7.1.3 GE Healthcare Angiographic Interventional Therapy System Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 GE Healthcare Angiographic Interventional Therapy System Product Offerings
7.1.5 GE Healthcare Recent Development
7.2 Koninklijke Philips N.V.
7.2.1 Koninklijke Philips N.V. Company Information
7.2.2 Koninklijke Philips N.V. Introduction and Business Overview
7.2.3 Koninklijke Philips N.V. Angiographic Interventional Therapy System Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Koninklijke Philips N.V. Angiographic Interventional Therapy System Product Offerings
7.2.5 Koninklijke Philips N.V. Recent Development
7.3 Siemens Healthineers
7.3.1 Siemens Healthineers Company Information
7.3.2 Siemens Healthineers Introduction and Business Overview
7.3.3 Siemens Healthineers Angiographic Interventional Therapy System Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Siemens Healthineers Angiographic Interventional Therapy System Product Offerings
7.3.5 Siemens Healthineers Recent Development
7.4 Canon Corporation
7.4.1 Canon Corporation Company Information
7.4.2 Canon Corporation Introduction and Business Overview
7.4.3 Canon Corporation Angiographic Interventional Therapy System Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Canon Corporation Angiographic Interventional Therapy System Product Offerings
7.4.5 Canon Corporation Recent Development
7.5 Boston Scientific Corporation
7.5.1 Boston Scientific Corporation Company Information
7.5.2 Boston Scientific Corporation Introduction and Business Overview
7.5.3 Boston Scientific Corporation Angiographic Interventional Therapy System Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Boston Scientific Corporation Angiographic Interventional Therapy System Product Offerings
7.5.5 Boston Scientific Corporation Recent Development
7.6 Cordis (a Cardinal Health Company, U.S.)
7.6.1 Cordis (a Cardinal Health Company, U.S.) Company Information
7.6.2 Cordis (a Cardinal Health Company, U.S.) Introduction and Business Overview
7.6.3 Cordis (a Cardinal Health Company, U.S.) Angiographic Interventional Therapy System Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Cordis (a Cardinal Health Company, U.S.) Angiographic Interventional Therapy System Product Offerings
7.6.5 Cordis (a Cardinal Health Company, U.S.) Recent Development
7.7 Shimadzu Corporation
7.7.1 Shimadzu Corporation Company Information
7.7.2 Shimadzu Corporation Introduction and Business Overview
7.7.3 Shimadzu Corporation Angiographic Interventional Therapy System Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Shimadzu Corporation Angiographic Interventional Therapy System Product Offerings
7.7.5 Shimadzu Corporation Recent Development
7.8 Medtronic
7.8.1 Medtronic Company Information
7.8.2 Medtronic Introduction and Business Overview
7.8.3 Medtronic Angiographic Interventional Therapy System Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Medtronic Angiographic Interventional Therapy System Product Offerings
7.8.5 Medtronic Recent Development
7.9 Terumo
7.9.1 Terumo Company Information
7.9.2 Terumo Introduction and Business Overview
7.9.3 Terumo Angiographic Interventional Therapy System Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Terumo Angiographic Interventional Therapy System Product Offerings
7.9.5 Terumo Recent Development
7.10 Braun Melsungen
7.10.1 Braun Melsungen Company Information
7.10.2 Braun Melsungen Introduction and Business Overview
7.10.3 Braun Melsungen Angiographic Interventional Therapy System Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Braun Melsungen Angiographic Interventional Therapy System Product Offerings
7.10.5 Braun Melsungen Recent Development
7.11 Abbott Laboratories
7.11.1 Abbott Laboratories Company Information
7.11.2 Abbott Laboratories Introduction and Business Overview
7.11.3 Abbott Laboratories Angiographic Interventional Therapy System Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Abbott Laboratories Angiographic Interventional Therapy System Product Offerings
7.11.5 Abbott Laboratories Recent Development
8 Industry Chain Analysis
8.1 Angiographic Interventional Therapy System Industrial Chain
8.2 Angiographic Interventional Therapy System Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Angiographic Interventional Therapy System Sales Model
8.5.2 Sales Channel
8.5.3 Angiographic Interventional Therapy System Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Angiographic Interventional Therapy System was estimated to be worth US$ 64030 million in 2025 and is projected to reach US$ 139080 million, growing at a CAGR of 11.9% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 142
USD 3950.00
(Single User License)
The global Angiographic Interventional Therapy System market was valued at US$ 64030 million in 2025 and is anticipated to reach US$ 139080 million by 2032, at a CAGR of 11.9% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 124
USD 2900.00
(Single User License)
The global Angiographic Interventional Therapy System market size was US$ 57840 million in 2024 and is forecast to a readjusted size of US$ 125640 million by 2031 with a CAGR of 11.9% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 96
USD 4250.00
(Single User License)
The global Angiographic Interventional Therapy System market is projected to grow from US$ 57840 million in 2024 to US$ 125640 million by 2031, at a CAGR of 11.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 157
USD 4900.00
(Single User License)
The global market for Angiographic Interventional Therapy System was valued at US$ 57840 million in the year 2024 and is projected to reach a revised size of US$ 125640 million by 2031, growing at a CAGR of 11.9% during the forecast period.
Published Date: 2025-01-13
Pages: 94
USD 2900.00
(Single User License)
The global Angiographic Interventional Therapy System market was valued at US$ 49330 million in 2023 and is anticipated to reach US$ 102520 million by 2030, witnessing a CAGR of 11.9% during the forecast period 2024-2030.
Published Date: 2024-01-12
Pages: 94
USD 2900.00
(Single User License)
The global market for Angiographic Interventional Therapy System was estimated to be worth US$ 64030 million in 2025 and is projected to reach US$ 139080 million, growing at a CAGR of 11.9% from 2026 to 2032.
Published: 2026-06-16
Pages: 142
The global Angiographic Interventional Therapy System market was valued at US$ 64030 million in 2025 and is anticipated to reach US$ 139080 million by 2032, at a CAGR of 11.9% from 2026 to 2032.
Published: 2026-04-17
Pages: 124
The global Angiographic Interventional Therapy System market size was US$ 57840 million in 2024 and is forecast to a readjusted size of US$ 125640 million by 2031 with a CAGR of 11.9% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 96
The global Angiographic Interventional Therapy System market is projected to grow from US$ 57840 million in 2024 to US$ 125640 million by 2031, at a CAGR of 11.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 157
The global market for Angiographic Interventional Therapy System was valued at US$ 57840 million in the year 2024 and is projected to reach a revised size of US$ 125640 million by 2031, growing at a CAGR of 11.9% during the forecast period.
Published: 2025-01-13
Pages: 94
The global Angiographic Interventional Therapy System market was valued at US$ 49330 million in 2023 and is anticipated to reach US$ 102520 million by 2030, witnessing a CAGR of 11.9% during the forecast period 2024-2030.
Published: 2024-01-12
Pages: 94
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now